It indicated that LUCAT1 was an oncogene that promoted the occurrence and development of tumors by affecting metabolic pathways in the tumor microenvironment and inhibiting the immune response of immune cells, resulting in a lousy prognosis. This evidence concerns the gene LUCAT1 and neoplasm.